Dasatinib-induced pulmonary arterial hypertension unresponsive to PDE-5 inhibition.
نویسندگان
چکیده
We read with interest the article ‘‘Src tyrosine kinase is crucial for potassium channel function in human pulmonary arteries’’ by NAGARAJ et al. [1]. The authors elegantly demonstrated that in physiological conditions, a low pulmonary vascular tone is maintained by Src family tyrosine kinase (SrcTK) and that inhibition of SrcTK will lead to vasoconstriction of pulmonary resistance arteries and thus to an increase in pulmonary artery pressure [1].
منابع مشابه
Pulmonary tumour thrombotic microangiopathy: unclassifiable pulmonary hypertension?
References 1 Simonneau G, Gatzoulis MA, Adatia I, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2013; 62: D34–D41. 2 Gurtner HP. Aminorex and pulmonary hypertension. A review. Cor Vasa 1985; 27: 160–171. 3 Kay JM, Smith P, Heath D. Aminorex and the pulmonary circulation. Thorax 1971; 26: 262–270. 4 Simonneau G, Fartoukh M, Sitbon O, et al. Primary pulmonary...
متن کاملRole of Src tyrosine kinases in experimental pulmonary hypertension.
OBJECTIVE Pulmonary arterial hypertension is a progressive pulmonary vascular disorder with high morbidity and mortality. Compelling evidence suggests that receptor tyrosine kinases, such as platelet-derived growth factor (PDGF) are closely involved in the pathogenesis of pulmonary arterial hypertension. We investigated the effects of 2 novel PDGF inhibitors, nilotinib/AMN107 (Abl kinases/PDGF ...
متن کاملCombination targeted pulmonary hypertension therapy in the resolution of Dasatinib-associated pulmonary arterial hypertension
Dasatinib is a small-molecule tyrosine kinase inhibitor used in the treatment of hematological malignancies. Pulmonary arterial hypertension (PAH) is a rare but known complication. The mainstay of treatment is cessation of Dasatinib, and while clinical improvement is rapid, complete hemodynamic resolution of pulmonary hypertension (PH) still remains exceedingly uncommon. We present a case of Da...
متن کاملAcute Effects of Vardenafil on Pulmonary Artery Responsiveness in Pulmonary Hypertension
Phosphodiesterase type-5 (PDE-5) inhibitors are novel and important options for the treatment of pulmonary arterial hypertension (PAH). Therefore, we aimed to examine effects of vardenafil, a PDE-5 inhibitor, on the pulmonary arteries isolated from rats with monocrotaline- (MCT-) induced pulmonary hypertension. MCT (60 mg/kg) or its vehicle was administered by a single intraperitoneal injection...
متن کاملTyrosine Kinases in experimental Pulmonary Hypertension
P ulmonary arterial hypertension (PAH) is a progressive pulmonary vascular disorder with high morbidity and mortality. 1 Current therapeutic approaches for the treatment of PAH mainly provide symptomatic relief, as well as some improvement in prognosis. Pathological changes observed in vascular remodeling include endothelial injury, proliferation, and migration of pulmonary arterial smooth musc...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- The European respiratory journal
دوره 42 3 شماره
صفحات -
تاریخ انتشار 2013